Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population-Reference-Cited by-同舟云学术

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population

Published:2022-07-13 Issue:1 Volume:19 Page:214-225
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Walpole Imogen¹,Lee Belinda¹²³,Shapiro Jeremy⁴⁵,Thomson Benjamin⁶⁷,Lipton Lara⁴⁷⁸,Ananda Sumitra⁷⁸,Usatoff Val⁴⁸,Mclachlan Sue‐Ann³⁹,Knowles Brett⁷⁹,Fox Adrian⁹¹⁰,Wong Rachel²⁵¹⁰¹¹,Cooray Prasad¹²,Burge Matthew¹³,Clarke Kate¹⁴,Pattison Sharon¹⁵,Nikfarjam Mehrdad³¹⁶¹⁷,Tebbutt Niall¹⁶,Harris Marion¹⁸,Nagrial Adnan¹⁹,Zielinski Rob²⁰²¹²²,Chee Cheng Ean²³,Gibbs Peter²³

Affiliation:

1. Department of Medical Oncology Northern Hospital Victoria Australia

2. Walter and Eliza Hall Institute Melbourne Victoria Australia

3. Faculty of Medicine & Health Sciences Faculty fo Medicine University of Melbourne Victoria Australia

4. Department of Medical Oncology Cabrini Health Malvern Victoria Australia

5. Faculty of Medicine & Health Sciences Monash University Victoria Australia

6. Department of Surgery University of Melbourne Royal Melbourne Hospital Victoria Australia

7. Department of Medical Oncology Peter MacCallum Cancer Centre Victoria Australia

8. Department of Medical Oncology Western Health Victoria Australia

9. Department of Medical Oncology St Vincent's Hospital Victoria Australia

10. Department of Medical Oncology Eastern Health Victoria Australia

11. Department of Medical Oncology Epworth Hospital Victoria Australia

12. Department of Medical Oncology Knox Private Hospital Victoria Australia

13. Department of Medical Oncology Royal Brisbane Hospital Queensland Australia

14. Department of Medical Oncology Wellington Hospital Wellington New Zealand

15. Department of Medicine Dunedin School of Medicine University of Otago Dunedin New Zealand

16. Department of Medical Oncology Austin Health Victoria Australia

17. Department of Surgery Warringal Private Hospital Victoria Australia

18. Department of Medical Oncology Monash Medical Centre Victoria Australia

19. Department of Medical Oncology Westmead Hospital New South Wales Australia

20. Department of Medical Oncology Orange Hospital New South Wales Australia

21. Department of Medical Oncology Dubbo Base Hospital New South Wales Australia

22. Department of Medical Oncology Bathurst Base Hospital New South Wales Australia

23. Department of Medical Oncology National University Cancer Institute Singapore

Funder

Pancare Foundation

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13807

Reference46 articles.

1. Australian Bureau of Statistics. Leading causes of death Australia‐selected years– 2009 2013 2018. Australian Bureau of Statistics.https://www.abs.gov.au/ausstats/abs@.nsf/0/47E19CA15036B04BCA2577570014668B?Opendocument. Accessed 3 May 2020.

2. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study

4. Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama;BMC Cancer;2023-06-06